MAGEA9 and gastric cancer: We selected nine proteins—NOSTRIN, GREM1, BAG2, OLFM4, TRIP6, IGFBP7, P3H3, LIPF, and MAGE-A9 based on their differential expression in the diffuse and intestinal subtypes and because they had not been studied in the diffuse and intestinal subtypes of gastric cancer.